Implications
obesity, cardiometabolic diseases, cardiometabolic disease
OBESITY, DISEASE, INSULIN SENSITIVITY
Study findings suggest that workplace SSB sales bans may be a promising addition to the existing arsenal of public health prevention strategies for combating obesity and cardiometabolic disease. As evidence of their effectiveness accumulates, employers may be incentivised to adopt these policies, given rising healthcare costs and productivity losses due to cardiometabolic diseases for which heavy SSB consumption is a known risk factorSSB sales bans may also have inherent advantages for health equity promotion that should be pursued in the future studies. Current prevention strategies used in the workplace, such as the US Centers for Disease Control and Prevention’s To maximise their impact for real-world policymaking, future trials of SSB sales bans should examine outcomes other than SSB consumption, including more distal and biological measures of cardiometabolic disease (e.g. insulin sensitivity). Because effect sizes from this study are smaller than those found in a prior study